Welcome to Sun-shine chemical
+86-17702719238 sales@sun-shinechem.com

Products

Catalog NoChemical NameCAS NumberPurityChemical Structure
2061310GW284543790186-68-498% Min.
GW284543, also known as UNC10225170;, is a potent and selective MEK5 inhibitor with t
206103G-1881639-98-198% Min.
G-1 is a selective agonist for GPER. It acts by blocking tubulin polymerization.
203401Glumetinib1642581-63-298% Min.
Glumetinib, also known as SCC244, is a novel, potent and highly selective inhibitor o
111892GNE-28611394121-05-198% Min.
GNE-2861 is a potent and exquisitely kinase-selective Group II PAK inhibitor (PAK4 Ki
193293GSK-1991549811-53-1>98%
GSK199 is a selective PAD4 inhibitor with half-maximum inhibitory concentration (IC50
193221GS-6265101637770-13-8>98%
GS-626510 is a potent BET family bromodomains inhibitor. It acts by targeting BRD2/3/
193194GSK2837808A1445879-21-9>98%
GSK2837808A is a potent, selective lactate dehydrogenase A (LDHA) inhibitor (IC50 val
193185GSK-9632049868-46-2>98%
GSK-963, also known as GSK'963 or GSK963, is a potent and selective inhibitor of
192284GNE-96051536200-31-3>98%
GNE-9605 is a highly potent, selective, and brain-penetrant aminopyrazole leucine-ric
192281GSK30047742138814-32-9>98%
GSK3004774 is a potent, nonabsorbable agonist of CaSR, with an pEC50 of 7.3, 6.6 and
192251GW-3965 HCl405911-17-3>98%
GW-3965 is a liver X receptor agonist. GW3965 represses the production of pro-inflamm
192224GSK23344701227911-45-6>98%
GSK2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (
192201GSK269962 HCl2095432-71-4>98%
GSK269962 is a selective ROCK inhibitor with IC50 values of 1.6 and 6 nM for ROCK-I a
192194GW-803430515141-51-2>98%
GW-803430 is a potent, orally active and selective melanin-concentrating hormone rece
192181GNE-4771032754-81-6>98%
GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor.
191255GSKJ11373422-53-7>98%
GSKJ1 is a selective and potent histone demethylase inhibitor (GSK-J1) that has signi
191144GSK2643943A//>98%
GSK2643943A is a potent USP20 inhibitor with IC50 = 160 nM.
19185GSK-28072245255-65-4>98%
GSK-2807 is a potent and selective, SAM-competitive inhibitor of SMYD3.
1812291GNE-66402009273-67-8>98%
GNE-6640 is a novel selective USP7 inhibitor, inducing tumor cell death. GNE-6640 enh
1812102GSK19400291150701-66-8>98%
GSK1940029, also known as SCD Inhibitor 1, is a SCD Inhibitor. GSK1940029 is a potent
181241GSK28143381420367-28-7>98%
GSK2814338, also known as Lp-PLA2 -IN-1, is a Lp-PLA2 inhibitor.
1811301GDC-09271642297-01-5>98%
GDC-0927, also known as SRN-927, is a next-generation oral SERD which appears to have
1811266GSK-5959901245-65-6>98%
GSK-5959 is a potent and selective BRPF1 bromodomain inhibitor (IC50 = 80 nM).
1811263GW-870086827319-43-7>98%
GW-870086 is a glucocorticoid receptor agonist potentially for the treatment of asthm
1811233GSK93111923851-49-3>98%
GSK9311 is a potent and highly selective inhibitor of the BRPF bromodomain (BRPDF1 pI
1811231GW1100306974-70-9>98%
GW1100 is a a selective antagonist of GPR40.
181151GW6471880635-03-0>98%
GW6471 is a PPAR α antagonist (IC50 = 0.24 μ M). GW6471 enhances the binding affini
1810292GSK-28303711404456-53-6>98%
GSK 2830371 is a WiP1 inhibitor. It inhibits cell growth and tumor growth in lymphoma
1810176GENZ-8827062070864-35-4>98%
GENZ-882706 is a potent colony stimulating factor-1 receptor (CSF-1R) Inhibitor.
189272GDC-05751196541-47-5>98%
GDC-0575 (ARRY-575, RG7741) is a potent and selective CHK1 inhibitor with an IC50 of